Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants
Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants, study reveals Novavax published ‘positive data’ from a phase 1 trial of its coronavirus vaccine in the New England Journal of Medicine on Friday All 108 volunteers dosed with the vaccine developed a antibodies to coronavirus after their second shot Novavax is launching its … Read more